Latest & greatest articles for anticoagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on anticoagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on anticoagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for anticoagulation

61. Comparative efficacy of anticoagulant versus antiplatelet therapy for stroke prevention in patients with embolic stroke of undetermined source (ESUS): a systematic review and meta-analysis of randomized controlled trials

Comparative efficacy of anticoagulant versus antiplatelet therapy for stroke prevention in patients with embolic stroke of undetermined source (ESUS): a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

62. Efficacy and safety of Xa inhibitors in patients with heart failure but without long-term anticoagulation: a meta-analysis of randomized controlled trials

Efficacy and safety of Xa inhibitors in patients with heart failure but without long-term anticoagulation: a meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

63. Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials using a direct oral anticoagulant

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials using a direct oral anticoagulant Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

64. Oral anticoagulants compared to antiplatelet or placebo in adult patients with chronic heart failure in sinus rhythm and reduced ejection fraction: a systematic review

Oral anticoagulants compared to antiplatelet or placebo in adult patients with chronic heart failure in sinus rhythm and reduced ejection fraction: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

65. A systematic summary of systematic reviews on anticoagulant therapy in sepsis

A systematic summary of systematic reviews on anticoagulant therapy in sepsis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

66. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and network meta-analysis

Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

67. Hemorrhagic risk in patients treated with aspirin vs. non-vitamin-K oral anticoagulants at doses approved for atrial fibrillation: systematic review and meta-analysis of randomized controlled trials

Hemorrhagic risk in patients treated with aspirin vs. non-vitamin-K oral anticoagulants at doses approved for atrial fibrillation: systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

68. Extracorporeal membrane oxygenation without therapeutic anticoagulation in adult patients: a systematic review of the current literature

Extracorporeal membrane oxygenation without therapeutic anticoagulation in adult patients: a systematic review of the current literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

69. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: systematic review and meta-analysis

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

70. Oral implants and risk of bleeding in patients taking antiplatelet or oral anticoagulation therapy. A systematic review

Oral implants and risk of bleeding in patients taking antiplatelet or oral anticoagulation therapy. A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

71. Anticoagulants for thromboprophylaxis in ambulatory patients with cancer

Anticoagulants for thromboprophylaxis in ambulatory patients with cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

72. Adherence to oral anticoagulants for treatment of atrial fibrillation in the Middle East: a systematic review

Adherence to oral anticoagulants for treatment of atrial fibrillation in the Middle East: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

73. Catheter assisted thrombolysis plus anticoagulation or anticoagulation alone for treating patients with iliofemoral vein thrombosis: a meta-analysis of randomized trials

Catheter assisted thrombolysis plus anticoagulation or anticoagulation alone for treating patients with iliofemoral vein thrombosis: a meta-analysis of randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

74. Effectiveness of anticoagulant therapy for antiphospholipid syndrome: a systematic review of randomised trials with focus on outcome reporting

Effectiveness of anticoagulant therapy for antiphospholipid syndrome: a systematic review of randomised trials with focus on outcome reporting Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

75. Effectiveness and harms of anti-aggregating therapy compared with anticoagulation therapy in patients with blunt carotid injury to lower stroke, bleeding and mortality risk: systematic review and meta-analysis

Effectiveness and harms of anti-aggregating therapy compared with anticoagulation therapy in patients with blunt carotid injury to lower stroke, bleeding and mortality risk: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD

2019 PROSPERO

76. What is the most clinically and cost effective combination of antiplatelet and anticoagulant therapies for people who have had an ACS and a separate indication for anticoagulation?

What is the most clinically and cost effective combination of antiplatelet and anticoagulant therapies for people who have had an ACS and a separate indication for anticoagulation? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

77. Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis [Cochrane protocol]

Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

78. Meta-analysis of minimally interrupted non-vitamin K oral anticoagulants versus uninterrupted use of non-vitamin K oral anticoagulants in atrial fibrillation catheter ablation

Meta-analysis of minimally interrupted non-vitamin K oral anticoagulants versus uninterrupted use of non-vitamin K oral anticoagulants in atrial fibrillation catheter ablation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

79. Non-vitamin K antagonist oral anticoagulants for cancer associated thrombosis: are there differences between real-world practice and trials? A critical systematic review and meta-analysis

Non-vitamin K antagonist oral anticoagulants for cancer associated thrombosis: are there differences between real-world practice and trials? A critical systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

80. Direct oral anticoagulation versus warfarin for postoperative atrial fibrillation following cardiac surgery: a systematic review and meta-analysis

Direct oral anticoagulation versus warfarin for postoperative atrial fibrillation following cardiac surgery: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO